<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T14:35:32Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.38451" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.38451</identifier>
    <datestamp>2026-06-08T14:31:50Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-06-08</dc:date>
  <dc:title>CLCC1 prevents acetaminophen‑induced liver injury through modulation of ER-mitochondria Ca&amp;sup2;⁺ flux and suppression of ROS‑JNK signaling</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.38451</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>CLCC1 FLOX and HKO primary hepatocytes were treated with Veh or 15 mM APAP for 24 h, with the following group sizes: FLOX+Veh (n = 3), FLOX+APAP (n = 4), and HKO+APAP (n = 4).</dc:description>
  <dc:subject>CLCC1; APAP; DILI</dc:subject>
  <dc:creator>谢岑</dc:creator>
  <dc:creator>江杰</dc:creator>
  <dc:creator>杨荣</dc:creator>
  <dc:rights>EMBARGO</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>